Metropolis to Quadruple Genomics Test Menu to 500 in Two Years
Companies
C
CNBC TV18•13-01-2026, 16:20
Metropolis to Quadruple Genomics Test Menu to 500 in Two Years
- •Metropolis Healthcare plans to expand its genomics test menu from 220 to 500 tests over the next two years.
- •Genomics tests are crucial for diagnosing cancer, stroke, immune disorders, and rare genetic conditions, enabling faster and more accurate treatment.
- •The company has launched a Centre for Genomics to enhance specialty testing and advanced diagnostics in India, combining testing with genetic counseling and bioinformatics.
- •Metropolis aims for 13-15% organic growth in FY26-FY27 and expects genomics to support margin expansion.
- •Metropolis is also expanding basic radiology services and evaluating entry into CT scans and MRI services, while focusing on internal capability building for genomics.
Why It Matters: Metropolis Healthcare is aggressively expanding its genomics testing capabilities and advanced diagnostics in India.
✦
More like this
Loading more articles...
